


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.27%
+12.08%
-3.87%
+2.73%
-1.11%
CYCN
Cyclerion Therapeutics In
$1.46
CYCN Price Performance
$1.52 (-3.95%)
$2.25 (-35.11%)
$2.51 (-41.83%)
$3.92 (-62.76%)
CYCN has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

CYCN overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
CYCN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CYCN Street Sentiment is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is CYCN current stock price?
What are CYCN stock strengths?
What is CYCN Risk Level?
What is CYCN market cap and volume?
What is CYCN current Stock IQ?
Should I buy CYCN stock right now?
Is CYCN a Strong Buy right now?
What does a 'Strong Buy' rating mean for CYCN?
What does a 'Strong Sell' rating mean for CYCN?
What factors influence CYCN's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.27%
+12.08%
-3.87%
+2.73%
-1.11%
CYCN
Cyclerion Therapeutics In
Current Price
$1.46
CYCN Stock IQ
Stock Insights
Not Enough Information

CYCN Price Performance
$1.52 (-3.95%)
$2.25 (-35.11%)
$2.51 (-41.83%)
$3.92 (-62.76%)
CYCN Analysts Opinion
CYCN Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
CYCN Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CYCN Street Sentiment is extremely bullish and have negative views on the near-term outlook
CYCN has Fair risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Price under $5

High volatilty

Average key support and resistance price levels
CYCN Latest Analysis
Cyclerion Therapeutics Inc. (CYCN) Discusses Medsteer Development Collaboration and Updates on Phase 2 Proof-of-Concept Study in Treatment-Resistant Depression Prepared Remarks Transcript.
Tue Jan 6, 2026
Why Cyclerion Therapeutics Shares Are Trading Higher By 44%. Here Are 20 Stocks Moving Premarket. Shares of ) rose sharply in pre-market trading after the company announced it is expanding strategic collaboration with Medsteer to advance closed-loop Cyclerion Therapeutics shares surged 44.2% to $1.99 in the pre-market trading session.Here are some other stocks moving in pre-market trading.) gained 40.9% to $0.47 in pre-market trading after rising 8% on Monday.AEVA) rose 24.2% to $16.26 in pre-ma
Tue Jan 6, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CYCN Stock trends
CYCN Stock performance
CYCN Stock analysis
CYCN investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.